SCHEMBL455320

SCHEMBL455320

C=CCCCCCCCC=O

nearest known ligand 0.53

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HIF1A Q16665 1/20 0.53
TSHR P16473 4/20 0.52
MAPT P10636 3/20 0.50
ABCC4 O15439 1/20 0.50
FAAH O00519 2/20 0.46
TRPV1 Q8NER1 1/20 0.46
ALDH1A1 P00352 4/20 0.43
LPAR3 Q9UBY5 2/20 0.43
LMNA P02545 2/20 0.43
LPAR2 Q9HBW0 1/20 0.43
TRPA1 O75762 2/20 0.41
USP2 O75604 2/20 0.37
CYP3A4 P08684 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
RECQL P46063 1/20 0.37
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31049855 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH
SCHEMBL17696302 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH
SCHEMBL515887 1.00
SCHEMBL7522844 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH
SCHEMBL5336674 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH
SCHEMBL107549 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH
SCHEMBL24287754 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH
SCHEMBL9246360 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH
SCHEMBL1701705 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH
SCHEMBL31049873 1.00 HIF1A (0.53) HIF1ATSHRMAPTABCC4FAAH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 580 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4711010-A2 PRO-PERFUME COMPOSITIONS Firmenich SA (CH) 2026-03-18 EP claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
EP-3784707-B1 STABLE POLYUREA MICROCAPSULE COMPOSITIONS INT FLAVORS & FRAGRANCES INC (US) 2025-12-24 EP claimed
US-20250325463-A1 COMPOSITIONS (III) SYMRISE AG (DE) 2025-10-23 US claimed
EP-4602141-A1 A FRAGRANCE MIXTURE (VI) Symrise AG (DE) 2025-08-20 EP claimed
CN-119968452-A Perfume mixture (VI) 西姆莱斯股份公司 2025-05-09 CN claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 US claimed
EP-3325588-B1 PERFUME COMPOSITIONS GIVAUDAN SA (CH) 2025-04-16 EP claimed
EP-4532646-A1 A FRAGRANCE MIXTURE (V) Symrise AG (DE) 2025-04-09 EP claimed
CN-119790128-A Perfume mixture (III) 西姆莱斯股份公司 2025-04-08 CN claimed
CN-111093374-A Stabilized formulation containing prothioconazole with low content of desulfurates 拜耳股份公司 2020-05-01 CN claimed
CN-105050996-B The manufacturing method of dialdehyde 株式会社可乐丽 2018-05-29 CN claimed
EP-3157948-A1 LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) 2017-04-26 EP claimed
US-20170044230-A1 LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) 2017-02-16 US claimed
US-9464018-B2 Method for producing dialdehyde KURARAY CO., LTD. (JP) 2016-10-11 US claimed
US-20160052852-A1 METHOD FOR PRODUCING DIALDEHYDE KURARAY CO., LTD. (JP) 2016-02-25 US claimed
EP-2980060-A1 METHOD FOR PRODUCING DIALDEHYDE Kuraray Co., Ltd. (JP) 2016-02-03 EP claimed
WO-2015197037-A1 LONG-ACTING STABLE PEPTIDE GHRELIN ANALOGS FOR THE TREATMENT OF CACHEXIA USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) 2015-12-30 WO claimed
CN-105050996-A Method for producing dialdehyde KURARAY CO 2015-11-11 CN claimed
EP-0442558-A1 Fatty acid-specific lipase UNILEVER N.V. (NL) 1991-08-21 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 HIF1A 257/4885TSHR 3559/4885MAPT 4309/4885
US-20160052852-A1 METHOD FOR PRODUCING DIALDEHYDE ENO1, ALDH1A2, DERA HIF1A 813/4885TSHR 1356/4885MAPT 4752/4885
US-20250325463-A1 COMPOSITIONS (III) NISCH, TAS1R3, TAS2R3 HIF1A 901/4885TSHR 2980/4885MAPT 3311/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.